IL-6 and GM-CSF in tumor rejection model of renal cell cancer

Advances in Experimental Medicine and Biology

Volumn 495, Issue , 2001, Pages 379-383

  Wysocki, Piotr J ^a   Kowalczyk, Dariusz W ^a   Izycki, Dariusz ^a   Grabarczyk, Piotr ^a   Kwias, Zbigniew ^a   Mackiewicz, Andrzej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER MODEL; CELL INFILTRATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA MODIFICATION; GENETIC TRANSDUCTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REJECTION;

ANIMALIA;

EID: 0035701943     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0685-0_55     Document Type: Conference Paper

References (5)

1. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes
2. The potential antitumor effects of combined p16 gene and GM-CSF gene therapy through efficient induction of antitumor immunity
3. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells
4. Soluble interleukin 6 receptor is biologically active in vivo
5. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and naïve angigen